FY25 · Released 28 August 2025
Me Today FY25: revenue grew, solvency worsened
Sales rose 48%, but the King Honey drag, equity deficit, and limited cash leave the balance sheet as the central issue.
Read briefing
MEE · NZX
Me Today
Consumer WellnessCovered: FY251 published briefing
Snapshot
Latest metrics
FY25, released 28 August 2025
| Metric | Value |
|---|---|
| Revenue | $7.5m |
| EBITDA | -$4.8m |
| NPAT | -$6.0m |
| Operating cash flow | -$0.9m |
| OCF / EBITDA % | 19.7% |
| Net debt | $14.5m |
| Net debt / EBITDA | -3.05x |
| PBT | -$6.0m |
| Debtor days | 67 |
| Inventory days | 548 |
Longitudinal view
Performance over time
Current-period values from each published briefing, with the most recent reporting period shown first.
| Metric | FY2528 August 2025 |
|---|---|
| Revenue | $7.5m |
| Revenue growth % | 48.2% |
| EBITDA | -$4.8m |
| EBITDA margin % | -63.8% |
| PBT | -$6.0m |
| NPAT | -$6.0m |
| Operating cash flow | -$0.9m |
| OCF / EBITDA % | 19.7% |
| Net debt | $14.5m |
| Net debt / EBITDA | -3.05x |
| Debtor days | 67 |
| Inventory days | 548 |
| Total assets | $15.2m |
Timeline
Briefing timeline
Reverse chronological, with each entry linking back to the full briefing.
Accountability
Expectations tracker
Once a second briefing exists for this company, this section will compare the previous briefing's expectations and unresolved issues with what actually happened in the next result.
Subscribe
Want the next Me Today briefing delivered to your inbox?
Subscribe to get future Annolyse briefings as soon as they are published.